RT Journal Article
SR Electronic
T1 Right hemispheric white matter hyperintensities improve the prediction of spatial neglect severity in acute stroke
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.08.22273547
DO 10.1101/2022.04.08.22273547
A1 Lisa Röhrig
A1 Christoph Sperber
A1 Leonardo Bonilha
A1 Christopher Rorden
A1 Hans-Otto Karnath
YR 2022
UL http://medrxiv.org/content/early/2022/04/12/2022.04.08.22273547.abstract
AB White matter hyperintensities (WMH) are frequently observed in brain scans of elderly people. They are associated with an increased risk of stroke, cognitive decline, and dementia. However, it is unknown yet if measures of WMH provide information that improve the understanding of poststroke outcome compared to only state-of-the-art stereotaxic structural lesion data. We implemented high-dimensional machine learning models, based on support vector regression (SVR), to predict the severity of spatial neglect in 103 acute right hemispheric stroke patients. We found that (1) the additional information of right hemispheric voxel-based topographic WMH extent indeed yielded an improvement in predicting acute neglect severity (compared to the voxel-based stroke lesion map alone). (2) Periventricular WMH appeared more relevant for prediction than deep subcortical WMH. (3) Among different WMH measures, voxel-based maps as measures of topographic extent allowed more accurate predictions compared to the use of traditional ordinally assessed visual rating scales (Fazekas scale, Cardiovascular Health Study scale). In summary, topographic WMH appears to be a valuable clinical imaging biomarker for predicting the severity of cognitive deficits and bears great potential for rehabilitation guidance of acute stroke patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Deutsche Forschungsgemeinschaft (KA 1258/23-1) and National Institutes of Health (P50DC014664).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of the medical faculty, University of Tübingen gave ethical approval for this work. The study was conducted in accordance with the Declaration of Helsinki.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData containing patient information cannot be made publicly available due to data protection restrictions by the local ethics commission. Remaining data and custom scripts are openly available in Mendeley Data (http://dx.doi.org/10.17632/c8n42jz525.1). https://data.mendeley.com/datasets/c8n42jz525/1